pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Phase 1
    CTT-1403
    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Cancer Targeted Technology LLC
  • Phase 1
    CTX-10726
    Endometrial Cancer$COMP Compass, Inc.
  • Phase 1
    CTX-8371
    Head And Neck Squamous Cell Carcinoma (HNSC)$COMP Compass, Inc.
← prev
page 16 of 62
next →
Pain89
Neurology1
Phase 2
CUE-101
Human Papillomavirus (HPV) Associated Cancer
$CUE Cue Biopharma, Inc.
  • Phase 1
    CUE-102
    Gastric Cancer$CUE Cue Biopharma, Inc.
  • Phase 1
    CUSP-06
    Ovarian Cancer OnCusp Therapeutics Inc
  • Phase 1
    CX-801
    Head And Neck Squamous Cell Carcinoma (HNSC)$CTMX CytomX Therapeutics, Inc.
  • Preclinical
    CXR-102
    Squamous Non-Small Cell Lung Carcinoma CorriXR Therapeutics Inc
  • Preclinical
    CYT-102
    Recurrent Glioblastoma Multiforme (GBM) Cytea Bio
  • Marketed
    Camptosar
    Camptosar (irinotecan hydrochloride)
    Colorectal Cancer$PFE PFIZER INC
  • Phase 2
    Cancer Program
    Metastatic Colorectal Cancer Mirror Biologics Inc
  • Phase 1
    Cantrixil
    Epithelial Ovarian Cancer Vivesto AB
  • Phase 2
    Carboxyamidotriazole Orotate
    Pravitinib
    Glioblastoma Multiforme (GBM) Tactical Therapeutics Inc
  • Phase 2
    Cellular Immunotherapy for Metastatic Melanoma, Peritoneal Cancer, Fallopian Tube Cancer and Epithelial Ovarian Cancer
    Metastatic Melanoma The Chaim Sheba Medical Center
  • Phase 1
    Central Memory-Enriched T Cells
    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk… City of Hope
  • Preclinical
    Culnexin Inhibitors
    Triple-Negative Breast Cancer (TNBC) Culnexin Therapeutics LLC
  • Phase 2
    Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK)
    Refractory Acute Myeloid Leukemia Cincinnati Children's Hospital Medical Center
  • Phase 2
    D2C7-IT
    Glioblastoma Multiforme (GBM) Istari Oncology Inc
  • Phase 1
    D3L-001
    Gastric Cancer D3 Bio Inc
  • Phase 2
    D3S-002
    Non-Small Cell Lung Cancer D3 Bio Inc
  • Phase 1
    D3S-003
    Solid Tumor D3 Bio Inc
  • Phase 1
    DAC-002
    Small-Cell Lung Cancer Hangzhou DAC Biotech Co Ltd
  • Phase 1
    DAY-301
    Adenocarcinoma Of The Gastroesophageal Junction$DAWN Day One Biopharmaceuticals, Inc.
  • Phase 2
    DB-1310
    Metastatic Breast Cancer Duality Biotherapeutics Inc
  • Phase 2
    DB-1311
    Esophageal Squamous Cell Carcinoma (ESCC)$BNTX BioNTech SE
  • Phase 1
    DB-1317
    Gastric Cancer Duality Biotherapeutics Inc
  • Phase 2
    DB-1324
    Gastrointestinal Tumor Duality Biotherapeutics Inc
  • Phase 2
    DB-1418
    Head And Neck Squamous Cell Carcinoma (HNSC) Avenzo Therapeutics Inc
  • Phase 2
    DB-1419
    Esophageal Squamous Cell Carcinoma (ESCC) Duality Biotherapeutics Inc
  • Phase 1
    DCC-2812
    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Deciphera Pharmaceuticals Inc